Navigation Links
Economy No Pour Pak® II Suction Catheter Kits

ProductsEconomy No Pour Pak® II Suction Catheter Kits
Company Portex
Item Economy No Pour Pak® II Suction Catheter Kits
Features 
  • Full kits offer total containment of contamination
  • The resealable basin has a snap-on lid which allows total containment of contaminated solution, catheter, and gloves
  • The efficient Maxi-Flo® catheter has a large opening on the distal tip that allows for easy, efficient removal of secretions
  • Economy No Pour Pak® II kits include all the features of the full kit, yet is more economical because it does not include the resealable lid
  • 20 units per case
Description The Maxi-Flo® suction catheter included with each kit maximizes suction efficiency and minimizes airway trauma.

All Portex® No Pour Pak® II suction catheter products are latex-free.

No Pour Pak® II suction catheter kits help minimize the risk of nosocomial infections, protecting the patient and clinician from exposure to contaminated material when the suctionprocedure is completed.
Info Portex
Customer Service: (603) 352-3812
Web site: http://www.smiths-medical.com

Related medicine products :

1. Precision Economy Incubators 3EM
2. Precision Economy Incubators 5EM
3. Precision Economy Incubators 2EG
4. Precision Economy Incubators 3EG
5. Precision Economy Incubators 5EG
6. Schiotz Tonometer Certified Calibration (Economy Model)
7. Economy
8. Economy Tie
9. Economy Velcro
10. Economy Buckle
11. Economy Coat
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes.
...aspiration holes and additional electrode tip insu...recise dissection with decreased risk of collatera... design options allow the choice between retractab...designs. Optimize specific surgical demands safely...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Medicine Products:
(Date:12/3/2008)...n television viewers will get,a chance to learn a... when the,documentary "The Brain That Changes Its... network. Based on the best-selling book of the sa...ary traces the development of the,science of neur...products and,customers of Posit Science Corporati...
(Date:12/3/2008)...ion Agency,s process of generating risk assessment...posed by harmful chemicals found in the environmen...own by unprecedented challenges, and as a decision...between available scientific data and the informat... National Research Council. EPA,s risk assessment...
(Date:12/3/2008)...8 , , LOVELAND, Ohio, Dec. 3 /PRNewswire/ ...a non-profit 501(c)(3) organization, is pleased to... new Methods Evaluation ProcessTM (MEPTM) Accredit...st a complimentary Webinar to provide an overview ...rder to make transparent attributions between inte...
(Date:12/3/2008)... a MED3OOO company that,delivers EHR technology t...nics, recently entered into a 14-year Application ...Care Alliance to provide electronic medical record... The WVVA Healthcare Alliance is made up of 30 ... Alleghany Highlands of Virginia and the Greenbrie...
Breaking Medicine News(10 mins):Health News:Posit Science Featured in Canadian Documentary on the Brain 2Health News:EPA's risk assessment process bogged down by unprecedented challenges; 2Health News:EPA's risk assessment process bogged down by unprecedented challenges; 3Health News:EPA's risk assessment process bogged down by unprecedented challenges; 4Health News:Population Health Impact Institute Invites Organizations To Serve as Test Sites for Methods Evaluation Process(TM) (MEP(TM)) Accreditation Program: 2Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 2Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 3Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 4
... Human Services (HHS) and its Centers for Disease ...Infant Immunization Week (NIIW) with events// Apri...the United States are expected to participate in N...ng the importance of timely infant and childhood v...
...parent failure by official bodies to halt the dist...ies have been incidents caused by E. coli contami...as well as pet food. Around 200 persons were aff...aminated with E.coli. A publicized incident was th...
...ences (AIIMS) has developed artificial testis, whi...r, underdeveloped genitals.// Doctors at the prem...ver 50 patients suffering from such problems, achi... "We are producing artificial testis and have trea...
...ed so high a priority in the minds of concerned he...here are moves to do away with regular school snac...are contributing to ungainly as well as dangerous ...the Institute of Medicine has been set up by the U...
Other Medicine News:Health News:National Infant Immunization Week Urges Parents to Vaccinate On Time 2Health News:U.S Officials Worried Over Failure In Preventing Food Contamination 2Health News:Artificial Testis Developed by AIIMS a Boon to Suffering Patients 2Health News:Weight Issues In Children-Experts Take Stock 2
(Date:12/2/2008)...LA JOLLA, Calif., Dec. 2 TorreyPin...unced positive results from a 26 patient Phase II ...ent for xerostomia, or dry mouth, in patients with...int of a statistically significant increase in sal...hree doses: 10 mg, 15 mg, and 20 mg. These doses w...
(Date:12/1/2008)... , , , CHICAGO, Dec. 2 /PRNewswire-USNe...n mammography (PEM), a new technique for imaging t...y or a woman,s hormonal status, two factors that l... MRI at detecting cancer. Results will be presente...Society of North America (RSNA). , , "The ...
(Date:12/1/2008)...INDIANAPOLIS, Dec. 1 Roche announc...aluate differences in perceived pain and,discomfo...CU-CHEK blood,glucose monitoring systems and lanc...sults indicated that, overall, the ACCU-CHEK Aviva...ing systems and the ACCU-CHEK Multiclix, ACCU-CHEK...
(Date:12/1/2008)...PLYMOUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCal... announced that dosing of subjects has begun in st...ing dose Phase 1b study of trodusquemine (MSI-1436...36 is a novel therapeutic for the treatment of typ... peripherally to regulate insulin and leptin pathw...
Breaking Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Use of PressureWire 28R 29 Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature Two New Studies Report 1611 1Use of PressureWire 28R 29 Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature Two New Studies Report 1611 2Use of PressureWire 28R 29 Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature Two New Studies Report 1611 3Actor Greg Grunberg Meets With the Epilepsy Advocates in Washington DC 15380 1Actavis Receives Approval of Generic Wellbutrin SR 28R 29 and Zyban 28R 29 Tablets in the U S 4241 1Actavis Receives Approval of Generic Wellbutrin SR 28R 29 and Zyban 28R 29 Tablets in the U S 4241 2Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting 1610 1Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting 1610 2Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting 1610 3
...S WIRE)--Jul 9, 2007 - TransPharma Medical,Ltd., a...evelopment,and commercialization of drug products ...livery technology, announced today,promising resul...e,safety and pharmacokinetic profile of its ViaDer...rosis., A seven day, repeated dose application, pa...
...E)--Jul 8, 2007 - Late-breaking Phase III,clinical...al,Society on Thrombosis and Haemostasis (ISTH) Co...ieved superior efficacy in the,prevention of venou...e replacement surgery in a head-to-head comparison...tients in the RECORD3,(REgulation of Coagulation i...
Other Medicine Technology:TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5